Type 1 diabetes

Global, regional and country‐specific burden of chronic kidney disease due to type 1 diabetes mellitus: A systematic analysis of the 2021 global disease burden study

Diabetes Obes MetabPublished Systematic analysis of the Global Burden of Disease 2021 study

Authors' conclusion

CKD-T1DM poses a growing public health threat, necessitating region-specific strategies that address healthcare inequities, promote early screening and prioritise nephroprotective therapies among T1DM populations.

Study context

Population
Global population, chronic kidney disease (CKD) due to T1D (CKD due to T1DM (CKD-T1DM)), 2021, by GBD super regions and countries
Outcome
Incidence, prevalence, deaths and DALYs (age-standardised rates) of CKD-T1DM
Follow-up
2021
Methodological detailsage-standardised rates, linear regression for temporal trends, age-period-cohort and Bayesian age-period-cohort (APC) projection models, sensitivity analysis with ARIMA and exponential smoothing models
  • Age-standardised rates
  • Linear regression for temporal trends
  • Age-period-cohort and Bayesian APC projection models
  • Sensitivity analysis with ARIMA and exponential smoothing models

Main finding

As reported in the abstract

Global burden of CKD-T1DM

Incident cases

95 140

Prevalent cases

6 295 711

Deaths

94 020

DALYs

3 875 628

Observational data: associations, not effects.

Further findings

Distribution of burden

Males and young-to-middle-aged individuals more likely affected
Middle-SDI regions at higher risk
Considerable variation across GBD super regions and countries

Temporal trends and projections · 1990–2021; projection to 2046

Number of patients with CKD-T1DM surged globally from 1990 to 2021
Projected continuous increase until 2046, driven by ageing populations and unmet therapeutic needs in low-resource settings

Original publication

Global, regional and country‐specific burden of chronic kidney disease due to type 1 diabetes mellitus: A systematic analysis of the 2021 global disease burden study. Diabetes Obes Metab. Published 21 March 2025. doi:10.1111/dom.16358

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.